PSMB8-AS1

 

Full name: PSMB8 antisense RNA 1 (head to head) Alias Symbol: XXbac-BPG246D15.8|TAP1-AS1
Type: non-coding RNA Cytoband: 6p21.32
Entrez ID: 100507463 HGNC ID: HGNC:39758 Ensembl Gene: ENSG00000204261 OMIM ID: 
Drug and gene relationship at DGIdb

 

Expression of PSMB8-AS1:

 

Dataset Gene EntrezID Probe Log2FC Adj.pValue Expression
GSE17351 PSMB8-AS1 100507463 1555852_at 0.1671 0.8679
GSE26886 PSMB8-AS1 100507463 1555852_at 0.8118 0.0569
GSE45670 PSMB8-AS1 100507463 1555852_at 0.2685 0.4652
GSE53622 PSMB8-AS1 100507463 941 0.3476 0.0206
GSE53624 PSMB8-AS1 100507463 19128 0.3032 0.0485
GSE63941 PSMB8-AS1 100507463 1555852_at 1.7457 0.1729
GSE77861 PSMB8-AS1 100507463 1555852_at -0.0002 0.9990
SRP007169 PSMB8-AS1 100507463 RNAseq 0.8657 0.1377
SRP008496 PSMB8-AS1 100507463 RNAseq 0.3391 0.3888
SRP064894 PSMB8-AS1 100507463 RNAseq 0.6423 0.0073
SRP133303 PSMB8-AS1 100507463 RNAseq 0.3346 0.0430
SRP159526 PSMB8-AS1 100507463 RNAseq -0.1418 0.7916
SRP193095 PSMB8-AS1 100507463 RNAseq 0.3069 0.0441
SRP219564 PSMB8-AS1 100507463 RNAseq 0.9405 0.0119

Upregulated datasets: 0; Downregulated datasets: 0.  


 

Survival by PSMB8-AS1 expression:

 

GSE53622GSE53624

 

Note: Click image to view full size file.  


Copy number change of PSMB8-AS1:

 

No record found for this gene.


 

Somatic mutations of PSMB8-AS1:

 

Generating mutation plots.

 

Highly correlated genes for PSMB8-AS1:

 

Showing top 20/268 corelated genes with mean PCC>0.5.
Gene1 Gene2 Mean PCC Num. Datasets Num. PCC<0 Num. PCC>0.5
PSMB8-AS1SLA0.759242404
PSMB8-AS1LAPTM50.754136404
PSMB8-AS1IL12RB10.748446404
PSMB8-AS1LAP30.736492404
PSMB8-AS1PLCB20.728778303
PSMB8-AS1GZMA0.728213505
PSMB8-AS1IL2RG0.727317303
PSMB8-AS1TAGAP0.726282303
PSMB8-AS1SUSD30.718476404
PSMB8-AS1GNGT20.718229303
PSMB8-AS1AIF10.716354404
PSMB8-AS1GMFG0.715104403
PSMB8-AS1FPR30.712124404
PSMB8-AS1CYTIP0.706304505
PSMB8-AS1HLA-F0.704106706
PSMB8-AS1FMNL10.703771303
PSMB8-AS1KCNA30.701303303
PSMB8-AS1BTN3A30.700029404
PSMB8-AS1STAP10.698718303
PSMB8-AS1GZMB0.698514505

For details and further investigation, click here